Galanos C - Search Results

1

Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients.

Engelhardt R, Mackensen A, Galanos C. Engelhardt R, et al. Among authors: galanos c. Cancer Res. 1991 May 15;51(10):2524-30. Cancer Res. 1991. PMID: 2021932 Clinical Trial.

2

Modulating activity of interferon-gamma on endotoxin-induced cytokine production in cancer patients.

Mackensen A, Galanos C, Engelhardt R. Mackensen A, et al. Among authors: galanos c. Blood. 1991 Dec 15;78(12):3254-8. Blood. 1991. PMID: 1720701 Free article.

3

Biological response to intravenously administered endotoxin in patients with advanced cancer.

Engelhardt R, Mackensen A, Galanos C, Andreesen R. Engelhardt R, et al. Among authors: galanos c. J Biol Response Mod. 1990 Oct;9(5):480-91. J Biol Response Mod. 1990. PMID: 2254760

4

Endotoxin (Salmonella abortus equi) in cancer patients. Clinical and immunological findings.

Engelhardt R, Otto F, Mackensen A, Mertelsmann R, Galanos C. Engelhardt R, et al. Among authors: galanos c. Prog Clin Biol Res. 1995;392:253-61. Prog Clin Biol Res. 1995. PMID: 8524930 Clinical Trial.

5

Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer.

Otto F, Schmid P, Mackensen A, Wehr U, Seiz A, Braun M, Galanos C, Mertelsmann R, Engelhardt R. Otto F, et al. Among authors: galanos c. Eur J Cancer. 1996 Sep;32A(10):1712-8. doi: 10.1016/0959-8049(96)00186-4. Eur J Cancer. 1996. PMID: 8983279 Clinical Trial.

6

Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients.

Kiani A, Tschiersch A, Gaboriau E, Otto F, Seiz A, Knopf HP, Stütz P, Färber L, Haus U, Galanos C, Mertelsmann R, Engelhardt R. Kiani A, et al. Among authors: galanos c. Blood. 1997 Aug 15;90(4):1673-83. Blood. 1997. PMID: 9269788 Free article. Clinical Trial.

7

Endotoxin tolerance: regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients.

Mackensen A, Galanos C, Wehr U, Engelhardt R. Mackensen A, et al. Among authors: galanos c. Eur Cytokine Netw. 1992 Nov-Dec;3(6):571-9. Eur Cytokine Netw. 1992. PMID: 1284277

8

Treatment of cancer patients with endotoxin induces release of endogenous cytokines.

Mackensen A, Galanos C, Engelhardt R. Mackensen A, et al. Among authors: galanos c. Pathobiology. 1991;59(4):264-7. doi: 10.1159/000163659. Pathobiology. 1991. PMID: 1715715 Clinical Trial.

9

Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953. Down-regulation of TNF-alpha and IL-6 is paralleled by an up-regulation of IL-1 beta and granulocyte colony-stimulating factor expression.

Knopf HP, Otto F, Engelhardt R, Freudenberg MA, Galanos C, Herrmann F, Schumann RR. Knopf HP, et al. Among authors: galanos c. J Immunol. 1994 Jul 1;153(1):287-99. J Immunol. 1994. PMID: 7515924

10

Induction of hypersensitivity to endotoxin and tumor necrosis factor by sublethal infection with Salmonella typhimurium.

Matsuura M, Galanos C. Matsuura M, et al. Among authors: galanos c. Infect Immun. 1990 Apr;58(4):935-7. doi: 10.1128/iai.58.4.935-937.1990. Infect Immun. 1990. PMID: 2180825 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters